• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Committee for New Health Technology Assessment (CNHTA) [Uterine endometrial ablation therapy by thermal balloon]
2010     Andalusian Health Technology Assessment Area (AETSA) [Immunogenicity and safety of prepandemic vaccines against H5N1 avian flu]
2010     Medical Advisory Secretariat (MAS) Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010     Committee for New Health Technology Assessment (CNHTA) [Hand transplantation]
2010     Andalusian Health Technology Assessment Area (AETSA) [Robot-assisted surgery using da Vinci robot telemanipulation in prostatectomy]
2010     NIHR Health Technology Assessment programme Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010     Committee for New Health Technology Assessment (CNHTA) [Thermoregulatory sweat test]
2010     Andalusian Health Technology Assessment Area (AETSA) [Robotic surgery by means of the da Vinci robotic telemanipulation system in cardiovascular surgery]
2010     NIHR Health Technology Assessment programme LIFELAX - diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial
2010     Medical Advisory Secretariat (MAS) Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010     Andalusian Health Technology Assessment Area (AETSA) [Robotic surgery by means of the da Vinci robotic telemanipulation system in general and digestive surgery]
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Andalusian Health Technology Assessment Area (AETSA) [Robotic surgery using the da Vinci robotic telemanipulation system in hysterectomy]
2010     NIHR Health Technology Assessment programme The effectiveness and cost effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model
2010     NIHR Health Technology Assessment programme Cetuximab for the first line treatment of metastatic colorectal cancer
2010     Medical Advisory Secretariat (MAS) Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010     Andalusian Health Technology Assessment Area (AETSA) [A study on efficacy, effectivity and efficiency of Intensity Modulated Radiotherapy (IMRT). Utility for treatment of breast and central nervous system neoplasms and sarcomas of bones and soft tissue]
2010     NIHR Health Technology Assessment programme Avoiding and identifying errors in health technology assessment models
2010     NIHR Health Technology Assessment programme Infliximab for the treatment of acute exacerbations of ulcerative colitis
2010     Andalusian Health Technology Assessment Area (AETSA) [Results from endovascular treatment in lower limb peripheral arterial disease]
2010     Andalusian Health Technology Assessment Area (AETSA) [Oxygen carriers. Production of red blood cells from human embryonic stem cells]
2010     Andalusian Health Technology Assessment Area (AETSA) [Mechanical thrombectomy with MERCI device. Ischaemic stroke]
2010     NIHR Health Technology Assessment programme Aripiprazole for the treatment of schizophrenia in adolescents (aged 15-17 years)
2010     Andalusian Health Technology Assessment Area (AETSA) [Gene expression test for breast cancer Oncotype]
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010     Andalusian Health Technology Assessment Area (AETSA) [Efficacy of oral/buccal insulin in the treatment of diabetes mellitus]
2010     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Medical device for intravesical microwave hyperthermia in the treatment of superficial bladder cancer
2010     Health Sciences Institute in Aragon (IACS) Complications of diabetes. Diabetic Neuropathy
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Hoftebeskyttere til forebyggelse af hoftebrud - en kommenteret udenlandsk medicinsk teknologivurdering
2010     Andalusian Health Technology Assessment Area (AETSA) [Mammaprint]
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Ældretræning i et MTV perspektiv
2010     NIHR Health Technology Assessment programme Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     Andalusian Health Technology Assessment Area (AETSA) [Deep brain stimulation in the treatment of depressive and obsessive-complusive disorders]
2010     NIHR Health Technology Assessment programme Golimumab for the treatment of rheumatoid arthritis after failure of previous disease-modifying antirheumatic drugs: a single technology appraisal
2010     Basque Office for Health Technology Assessment (OSTEBA) [Integrated intra and extra-hospital approach to conduct disorders in adolescence]
2010     NIHR Health Technology Assessment programme School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
2010     NIHR Health Technology Assessment programme Pazopanib for the first line treatment of patients with advanced and/or metastatic renal cell carcinoma: a single technology appraisal
2010     NIHR Health Technology Assessment programme Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost effectiveness and value of information analyses
2010     NIHR Health Technology Assessment programme Vinflunine for the second line treatment of transitional cell carcinoma of the urothelial tract
2010     Haute Autorite de sante (HAS) [Assessment of medical devices for home infusion]
2010     NIHR Health Technology Assessment programme Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
2010     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010     NIHR Health Technology Assessment programme Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, costeffectiveness and economic analysis
2010     NIHR Health Technology Assessment programme Chemoprevention of colorectal cancer: systematic review and economic model
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®)
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atazanavir (Reyataz®) capsules
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil citrate (Revatio®) solution
2010     Blue Cross Blue Shield Association (BCBS) Gene expression profiling in women with lymph-node-positive breast cancer to select adjuvant chemotherapy treatment
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) capsules
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2010     HAYES, Inc. Alair bronchial thermoplasty system (Asthmatx Inc.) for treatment of asthma
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) oral solution
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2010     Blue Cross Blue Shield Association (BCBS) Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin theta (Eporatio®)
2010     Blue Cross Blue Shield Association (BCBS) Low-level laser therapy for carpal tunnel syndrome and chronic neck pain
2010     HAYES, Inc. Autologous stem cell transplantation followed by nonmyeloablative allogeneic stem cell transplantation for treatment of multiple myeloma
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Transmural nutritional support]
2010     Blue Cross Blue Shield Association (BCBS) Radiofrequency ablation of nondysplastic or low-grade dysplastic barrett's esophagus
2010     Penn Medicine Center for Evidence-based Practice (CEP) Postpartum management of hypertensive disorders
2010     HAYES, Inc. Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Olanzapine depot (ZypAdhera)
2010     The Swedish Council on Health Technology Assessment (SBU) Antibiotic prophylaxis in surgical interventions
2010     Penn Medicine Center for Evidence-based Practice (CEP) Calibration of computerized drug interaction alerts
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Electrical stimulation for the treatment of headaches
2010     Penn Medicine Center for Evidence-based Practice (CEP) Albumin use in the healthcare setting
2010     HAYES, Inc. Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations
2010     VA Technology Assessment Program (VATAP) Gadolinium-containing contrast agents for patients with renal disease
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Tocilizumab for rheumatoid arthritis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of catheter-associated venous thrombosis
2010     HAYES, Inc. Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.)
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Digital dermoscopy in the diagnosis of melanoma
2010     Penn Medicine Center for Evidence-based Practice (CEP) Routine newborn monitoring immediately following birth
2010     HAYES, Inc. Chantix (Varenicline Tartrate) (Pfizer Inc.) for smoking cessation
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in acute abdominal pain]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of kinesiotaping]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Citoreductive Surgery + Hypertermic Intraperitoneal Quimiotherapy for peritoneal carcinomatosis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Pre-operative hair removal in different settings to decrease surgical site infections
2010     HAYES, Inc. ChloraPrep (CareFusion Corp.) for skin antisepsis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Preventing catheter-related bloodstream infections in home infusion patients
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Pandemic Influenza A Vaccine (H1N1)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Care management
2010     Haute Autorite de sante (HAS) [High intensity focalized ultrasound for the treatment of localized prostate cancer]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Permacol implants for hernia repair
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Clofarabine for the treatment of adult leukemia and lymphoma
2010     Penn Medicine Center for Evidence-based Practice (CEP) Adapting Penn Medicine's inpatient services to meet the ACGME's proposed duty hour regulations
2010     HAYES, Inc. Entereg (Alvimopan) (Adolor Corp.) to reduce postoperative ileus
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Cetuximab (Erbitux®) for third-line treatment of patients with KRAS wild-type metastatic colorectal cancer
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of retroperitoneal bleeding in coronary catheterization patients
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Chemoembolization of hepatocellular carcinoma with drug eluting beads (DC Beads)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of central venous catheters in hemodialysis patients with bloodstream infections
2010     HAYES, Inc. E-tegrity test (Hologic Inc.; distributed by Sepal Reproductive Devices) for evaluation of uterine receptivity
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [The disease burden of seasonal influenza and the effectiveness of seasonal influenza vaccination in Korea]
2010     Haute Autorite de sante (HAS) [Cardiac markers in coronary disease and heart failure in outpatient medicine]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for care after percutaneous coronary intervention (PCI)
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous aortic valve replacement for aortic stenosis]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for warfarin use in orthopedic surgery patients
2010     HAYES, Inc. HE4 assay (Fujirebio Diagnostics Inc.) on the Architect platform (Abbott Diagnostics) for ovarian cancer monitoring